01 2GlaxoSmithKline Inc.
01 22471363
01 2ALBIGLUTIDE
01 2POWDER FOR SOLUTION
01 22022-12-23
Patent Expiration Date : 2022-12-23
Date Granted : 2014-02-11
Brand Name : EPERZAN
Patent Number : 2471363
Filing Date : 2002-12-23
Strength per Unit : 30 mg / 0.5 mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2022-12-23
Date Granted : 2014-02-11
Patent Expiration Date : 2022-12-23
Date Granted : 2014-02-11
Brand Name : EPERZAN
Patent Number : 2471363
Filing Date : 2002-12-23
Strength per Unit : 50 mg / 0.5 mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2022-12-23
Date Granted : 2014-02-11
